Patents Assigned to IOGEN LLC
  • Patent number: 8691290
    Abstract: A method for killing or substantially eradicating a pathogen in the upper respiratory tract of a mammal is disclosed. The method comprises generating molecular iodine (I2) in situ using an oxidant-reductant reaction with a minimum concentration of at least about 25 ppm of I2 and I2 comprises at least 40% of the total iodine atoms. A method for inhibiting superantigens using molecular iodine is also disclosed.
    Type: Grant
    Filed: October 15, 2012
    Date of Patent: April 8, 2014
    Assignee: Iogen LLC
    Inventors: Jack Howard Kessler, James Carlton Richards
  • Publication number: 20130039997
    Abstract: A method for killing or substantially eradicating a pathogen in the upper respiratory tract of a mammal is disclosed. The method comprises generating molecular iodine (I2) in situ using an oxidant-reductant reaction with a minimum concentration of at least about 25 ppm of I2 and I2 comprises at least 40% of the total iodine atoms. A method for inhibiting superantigens using molecular iodine is also disclosed.
    Type: Application
    Filed: October 15, 2012
    Publication date: February 14, 2013
    Applicant: IOGEN LLC
    Inventor: IOGEN LLC